Published in Medical Letter on the CDC and FDA, September 29th, 1997
"The vaccine works and the vaccine is safe," Leonard Sigal, a researcher at the Robert Wood Johnson Medical School, New Brunswick, New Jersey, said of the vaccine, developed by a subsidiary of the Rhone-Poulenc Group.
The subsidiary, Pasteur Merieux Connaught, said preliminary results showed that the vaccine reduced the occurrence of Lyme disease in a clinical trial involving 10,306 adults.
John Zahradnik, Pasteur Merieux Connaught, said the promising results of the trial had led the company to prepare to submit a product license application to the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.